Gaweco AS et al. |
Distinct intragraft cytokine gene expression patterns during acute hepatic rejection under cyclosporine versus FK 506 primary immunosuppression. |
1994 |
Transplant. Proc. |
pmid:7527948
|
Burke GW et al. |
The use of FK506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression. |
1995 |
Transplant. Proc. |
pmid:8539874
|
Valdivia LA et al. |
Hamster-to-rat liver xenografts protect extrahepatic organs from rejection. |
1993 |
Transplant. Proc. |
pmid:7679816
|
Yasunami Y et al. |
Acceptance of donor-specific islet allografts in rat by intraportal preimmunization with islets and FK 506. |
1994 |
Transplant. Proc. |
pmid:7513467
|
Alejandro R et al. |
Combined liver-islet allotransplantation in man under FK 506. |
1991 |
Transplant. Proc. |
pmid:1703712
|
Grewal HP et al. |
Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636558
|
Tanabe K et al. |
Malabsorption of tacrolimus in kidney transplant recipients: a Japanese single center experience. |
2000 |
Transplant. Proc. |
pmid:11119906
|
Rossi G et al. |
Three-year follow-up of low dose tacrolimus oral therapy after liver transplantation: a single-centre experience. |
1998 |
Transplant. Proc. |
pmid:9636562
|
Wong KM et al. |
Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study. |
2000 |
Transplant. Proc. |
pmid:11119907
|
Yao B et al. |
The incidence of posttransplantation diabetes mellitus during follow-up in kidney transplant recipients and relationship to Fok1 vitamin D receptor polymorphism. |
2013 Jan-Feb |
Transplant. Proc. |
pmid:23375298
|
Ciancio G et al. |
Efficacy and safety of daclizumab induction for primary kidney transplant recipients in combination with tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression. |
2003 |
Transplant. Proc. |
pmid:12644172
|
Rath T and Küpper M |
Comparison of inosine-monophosphate-dehydrogenase activity in patients with enteric-coated mycophenolate sodium or mycophenolate mofetil after renal transplantation. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715967
|
Cofan F et al. |
Oxidation of low-density lipoproteins in renal transplant recipients treated with tacrolimus. |
2002 |
Transplant. Proc. |
pmid:11959335
|
Hoffman AL et al. |
The effect of FK 506 on small intestine allotransplantation in the rat. |
1990 |
Transplant. Proc. |
pmid:1689907
|
Lee KK et al. |
Successful orthotopic small bowel transplantation with short-term FK 506 immunosuppressive therapy. |
1990 |
Transplant. Proc. |
pmid:1689908
|
Todo S et al. |
Intestinal transplantation in humans under FK 506. |
1993 |
Transplant. Proc. |
pmid:7680148
|
Wu YM et al. |
Interaction between FK 506 and cyclosporine in dogs. |
1991 |
Transplant. Proc. |
pmid:1721281
|
Sung RS et al. |
Survival of human islet xenografts irradiated with ultraviolet B in diabetic rats. |
1996 |
Transplant. Proc. |
pmid:8623427
|
Lipson DA et al. |
Conversion to tacrolimus (FK506) from cyclosporine after orthotopic lung transplantation. |
1998 |
Transplant. Proc. |
pmid:9636612
|
Braun F et al. |
An ex vivo model to study the intestinal biotransformation of immunosuppressives. |
2000 |
Transplant. Proc. |
pmid:11120282
|
Ringe B et al. |
Replacement of corticosteroids by mycophenolate mofetil in liver graft recipients on initial tacrolimus immunosuppression. |
2000 |
Transplant. Proc. |
pmid:11120285
|
Vanrenterghem Y |
Vascular rejection with tacrolimus and potential long-term graft outcome. |
1999 |
Transplant. Proc. |
pmid:10576054
|
Iaria G et al. |
Prospective study of switch from cyclosporine to tacrolimus for fibroadenomas of the breast in kidney transplantation. |
2010 |
Transplant. Proc. |
pmid:20534252
|
Manzia TM et al. |
Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results. |
2010 |
Transplant. Proc. |
pmid:20534261
|
Woodle ES |
A prospective, randomized, multicenter, double-blind study of early corticosteroid cessation versus long-term maintenance of corticosteroid therapy with tacrolimus and mycophenolate mofetil in primary renal transplant recipients: one year report. |
2005 |
Transplant. Proc. |
pmid:15848538
|
Akiyama T et al. |
Mizoribine in combination therapy with tacrolimus for living donor renal transplantation: analysis of a nationwide study in Japan. |
2005 |
Transplant. Proc. |
pmid:15848551
|
Kahan BD |
Forty years of publication of transplantation proceedings--the second decade: the cyclosporine revolution. |
2009 |
Transplant. Proc. |
pmid:19545653
|
López-Montenegro Soria MA et al. |
Genetic polymorphisms and individualized tacrolimus dosing. |
2010 |
Transplant. Proc. |
pmid:20970601
|
Andrés A et al. |
Extended-release tacrolimus therapy in de novo kidney transplant recipients: single-center experience. |
2010 |
Transplant. Proc. |
pmid:20970602
|
Nowacka-Cieciura E et al. |
Late conversion to everolimus complicated with necrotizing glomerulonephritis in a renal allograft recipient: case report. |
2009 Jan-Feb |
Transplant. Proc. |
pmid:19249576
|
Metcalfe S et al. |
FK 506 and cyclosporine A: early effects on activation and gene induction in mouse spleen cells. |
1990 |
Transplant. Proc. |
pmid:1697107
|
Yasutomi M et al. |
Mechanism of antibody production in hamster-to-rat concordant xenotransplantation: establishment of a simple model using intravenous injection of concordant splenocytes. |
1994 |
Transplant. Proc. |
pmid:7518110
|
Takada Y et al. |
Energy metabolism of hepatic allografts subjected to prolonged warm ischemia and pharmacologic modulation with FK506 and platelet activating factor antagonist. |
1998 |
Transplant. Proc. |
pmid:9838621
|
Miyazawa H et al. |
Mechanisms of hamster kidney graft rejection in the rat. |
1994 |
Transplant. Proc. |
pmid:7518111
|
Mueller AR et al. |
The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine A. |
1995 |
Transplant. Proc. |
pmid:7533359
|
Abouljoud MS et al. |
Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group. |
1995 |
Transplant. Proc. |
pmid:7533360
|
Woo J et al. |
Kinetics of early T-cell repopulation in the mouse following syngeneic bone marrow transplantation: FK 506 causes a maturational defect of CD4+ CD8- T cells. |
1991 |
Transplant. Proc. |
pmid:1721313
|
Morozumi K et al. |
Diagnosis of chronic rejection using peritubular and glomerular capillary lesions. |
1996 |
Transplant. Proc. |
pmid:8644331
|
McCarthy SA et al. |
Effects of FK 506 and cyclosporine on T-cell tolerance: inhibition of a "protective" mechanism that regulates activation-induced apoptosis in developing thymocytes. |
1991 |
Transplant. Proc. |
pmid:1721314
|
Savikko J et al. |
Tacrolimus inhibits platelet-derived growth factor ligand and receptor induction as well as rejection changes in rat renal allografts during long-term follow-up. |
2002 |
Transplant. Proc. |
pmid:12176405
|
Akioka K et al. |
Abdominal pain is a critical complication of mycophenolate mofetil in renal transplant recipients. |
2003 |
Transplant. Proc. |
pmid:12591411
|
Hohage H et al. |
Differential effects of cyclosporine and tacrolimus on mycophenolate pharmacokinetics in patients with impaired kidney function. |
2005 |
Transplant. Proc. |
pmid:15919453
|
Masri MA |
Comparative study of toxicity and efficacy of cyclosporine, cyclosporine G (OG37), FK 506, and rapamycin in BALB/c mice with fitted skin grafts. |
1995 |
Transplant. Proc. |
pmid:7533412
|
Nakazato P et al. |
Early experience with FK 506 induction immunosuppression--suggestion for using oral FK 506. |
1991 |
Transplant. Proc. |
pmid:1721345
|
Borda B et al. |
Early histopathological changes in new-onset diabetes after kidney transplantation. |
|
Transplant. Proc. |
pmid:25131129
|
Reis A et al. |
Mycophenolate mofetil and FK506: two novel immunosuppressants in murine corneal transplantation. |
1998 |
Transplant. Proc. |
pmid:9865380
|
Emiroglu R et al. |
Tacrolimus-related neurologic and renal complications in liver transplantation: A single-center experience. |
2006 |
Transplant. Proc. |
pmid:16549190
|
Prates LC et al. |
Pain syndrome induced by calcineurin inhibitor and resolved by conversion to sirolimus in a child after kidney transplantation: a case report. |
2012 |
Transplant. Proc. |
pmid:23026634
|
Martin Garcia D et al. |
Tacrolimus-Basiliximab versus Cyclosporine-Basiliximab in renal transplantation "de novo": acute rejection and complications. |
2003 |
Transplant. Proc. |
pmid:12962761
|
Solà R et al. |
Tacrolimus in induction immunosuppressive treatment in renal transplantation: comparison with cyclosporine. |
2003 |
Transplant. Proc. |
pmid:12962763
|
Naraghi RM et al. |
Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123013
|
Nishi K et al. |
The colon displays an absorptive capacity of tacrolimus. |
2004 |
Transplant. Proc. |
pmid:15050160
|
Velio P et al. |
Rejection and survival after total orthotopic liver-small bowel allotransplantation in pigs immunosuppressed with FK 506. |
1996 |
Transplant. Proc. |
pmid:8907936
|
Sonnenday CJ et al. |
Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match. |
2002 |
Transplant. Proc. |
pmid:12176507
|
Bardella MT et al. |
FK 506 and cyclosporine: effect on D-xylose absorption in pigs with orthotopic liver-small bowel allotransplants. |
1996 |
Transplant. Proc. |
pmid:8907937
|
Ciancio G et al. |
Effect of daclizumab, tacrolimus and mycophenolate mofetil in racial minority first renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176508
|
Gringeri E et al. |
Neoadjuvant therapy protocol and liver transplantation in combination with pancreatoduodenectomy for the treatment of hilar cholangiocarcinoma occurring in a case of primary sclerosing cholangitis: case report with a more than 8-year disease-free survival. |
2011 |
Transplant. Proc. |
pmid:21620084
|
Matsuura T et al. |
Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation. |
1994 |
Transplant. Proc. |
pmid:7520616
|
Ota K |
Living donor kidney transplantation in Japan. |
1994 |
Transplant. Proc. |
pmid:7520622
|
Ueda D et al. |
Influence of FK 506 on renal blood flow. |
1991 |
Transplant. Proc. |
pmid:1721377
|
Thomson AW et al. |
The influence of FK 506 on the thymus: implications of drug-induced injury to thymic epithelial cells. |
1991 |
Transplant. Proc. |
pmid:1703361
|
Perico N et al. |
FK 506 does not affect the glomerular filtration rate and renal plasma flow in the rat. |
1991 |
Transplant. Proc. |
pmid:1721378
|
Mieles L et al. |
Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients. |
1991 |
Transplant. Proc. |
pmid:1703362
|
Rastellini C et al. |
Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083278
|
Millis JM et al. |
Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123421
|
Klupp J et al. |
New approach in drug development: whole blood pharmacodynamic assays reflect biological activities of tacrolimus. |
2001 |
Transplant. Proc. |
pmid:11377491
|
Mollison KW et al. |
Discovery of FK 506 analogues that are nontoxic to mouse pancreatic beta cells in vitro but show diabetogenic potential when administered to the rat. |
1996 |
Transplant. Proc. |
pmid:8962236
|
Pozzetto U et al. |
Effects of immunosuppressive regimens on plasma levels of transforming growth factor-beta 1 in renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176558
|
Mao PC et al. |
Trends in the use of immunosuppressive agents by outpatients after renal transplantation at a medical center in southern Taiwan. |
2012 |
Transplant. Proc. |
pmid:22310611
|
Tsai SF et al. |
Trends in maintenance immunosuppressive drugs used in taiwanese kidney transplant recipients: an analysis of the national health insurance research database. |
2012 |
Transplant. Proc. |
pmid:22310612
|
Pelekanou V et al. |
FK 506 and rapamycin do not affect platelet aggregation or mitochondrial function. |
1991 |
Transplant. Proc. |
pmid:1721408
|
Taki J et al. |
DNA analysis of peripheral blood mononuclear cells for early detection of hepatic graft rejection. |
1992 |
Transplant. Proc. |
pmid:1379760
|
Tai J et al. |
In vivo and in vitro effect of FK 506 on rat Leydig cell function. |
1991 |
Transplant. Proc. |
pmid:1721409
|
Calconi G and Vianello A |
One-year follow-up of a large European trial comparing dual versus triple tacrolimus-based immunosuppressive regimens following renal transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267173
|
Pretagostini R et al. |
Conversion from cyclosporin to tacrolimus in chronic allograft nephropathy. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267174
|
Dresske B et al. |
Synergistic impact of "WOFIE" on the immunosuppressive potency of FK 506 in a heterotopic heart transplantation model in the rat. |
1999 |
Transplant. Proc. |
pmid:10331001
|
Nayeri A et al. |
Acute Calcineurin Inhibitor Nephrotoxicity Secondary to Turmeric Intake: A Case Report. |
|
Transplant. Proc. |
pmid:28104136
|
Sicilia-Castro D et al. |
Reconstruction of a severe facial defect by allotransplantation in neurofibromatosis type 1: a case report. |
2011 |
Transplant. Proc. |
pmid:21911174
|
Dedhia P et al. |
Eculizumab and Belatacept for De Novo Atypical Hemolytic Uremic Syndrome Associated With CFHR3-CFHR1 Deletion in a Kidney Transplant Recipient: A Case Report. |
|
Transplant. Proc. |
pmid:28104134
|
Kanatani T et al. |
Donor leukocytes combine with immunosuppressive drug therapy to prolong limb allograft survival. |
2005 |
Transplant. Proc. |
pmid:15964421
|
Gnatta D et al. |
Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study. |
2010 |
Transplant. Proc. |
pmid:20304169
|
Behr TM et al. |
Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine A. |
1998 |
Transplant. Proc. |
pmid:9723333
|
Trotter JF |
Sirolimus in liver transplantation. |
2003 |
Transplant. Proc. |
pmid:12742496
|
Ventura E et al. |
Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring. |
2009 |
Transplant. Proc. |
pmid:19328963
|
Ojogho ON et al. |
Mycophenolate mofetil without antibody induction in pediatric renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12176641
|
van der Laan LJ et al. |
Results of a two-center study comparing hepatic fibrosis progression in HCV-positive liver transplant patients receiving cyclosporine or tacrolimus. |
2010 |
Transplant. Proc. |
pmid:21168740
|
Sato K et al. |
Comparative study of FK 506, cyclosporine, and triple regimen immunosuppression with FK 506, cyclosporine, and mizoribine. |
1991 |
Transplant. Proc. |
pmid:1721440
|
Gruttadauria S et al. |
A safe immunosuppressive protocol in adult-to-adult living related liver transplantation. |
2006 |
Transplant. Proc. |
pmid:16757278
|
Nanmoku K et al. |
Steroid Withdrawal Using Everolimus in ABO-Incompatible Kidney Transplant Recipients With Post-Transplant Diabetes Mellitus. |
2018 |
Transplant. Proc. |
pmid:29631750
|
Odocha O et al. |
Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression. |
1993 |
Transplant. Proc. |
pmid:7689268
|
Ochiai T et al. |
Effects of FK-506 on xenotransplantation of the heart and skin in a mouse-rat combination. |
1987 |
Transplant. Proc. |
pmid:2445083
|
Langrehr JM et al. |
IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267360
|
Chang HK et al. |
Ten-Year Experience With Bowel Transplantation at Seoul St. Mary's Hospital. |
2016 |
Transplant. Proc. |
pmid:27109981
|
González-Pinto I et al. |
Usefulness of the switch to tacrolimus in liver transplantation. |
1999 |
Transplant. Proc. |
pmid:10500653
|
Bárcena R et al. |
Immunosuppression in liver transplantation: a European survey. |
1999 |
Transplant. Proc. |
pmid:10500654
|
Nicholson ML et al. |
Is TGF-beta a profibrotic cytokine in human renal transplants? |
1998 |
Transplant. Proc. |
pmid:9636384
|
Garcia CD et al. |
Pediatric renal transplantation under tacrolimus or cyclosporine immunosuppression and basiliximab induction. |
2002 |
Transplant. Proc. |
pmid:12431513
|
Wang M et al. |
Acute influence of FK506 on T-lymphocyte populations of peripheral blood and spleen in rats. |
2007 Jan-Feb |
Transplant. Proc. |
pmid:17275526
|
Eghtesad B et al. |
Use of tacrolimus as the primary immunosuppression after renal transplant in Native Americans and Hispanics. |
1998 |
Transplant. Proc. |
pmid:9636500
|
Pichlmayr R et al. |
Three-year follow-up of the European Multicenter Tacrolimus (FK506) Liver Study. |
1997 |
Transplant. Proc. |
pmid:9270825
|